Dianthus Therapeutics to Webcast Presentation at the Jefferies Global Healthcare Conference

Rhea-AI Summary

Dianthus Therapeutics (NASDAQ: DNTH), a clinical-stage biotech company focused on developing next-generation antibody complement therapeutics for severe autoimmune diseases, has announced its participation in the upcoming Jefferies Global Healthcare Conference. CEO Marino Garcia will lead a fireside chat on June 5, 2025, at 9:55 a.m. EDT in New York City. The presentation will be accessible via webcast in the Investors section of the company's website under "News and Events". Additionally, the company's management will be available for one-on-one meetings with investors during the conference.

NEW YORK and WALTHAM, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today announced the Company’s participation in the Jefferies Global Healthcare Conference. Marino Garcia, Chief Executive Officer, will participate in a fireside chat on Thursday, June 5, 2025 at 9:55 a.m. EDT in New York City and will host one-on-one meetings with investors.

A live webcast of the Company’s presentation may be accessed under “News and Events” in the Investors section of the Dianthus Therapeutics website.

About Dianthus Therapeutics
Dianthus Therapeutics is a clinical-stage biotechnology company dedicated to designing and delivering novel, best-in-class monoclonal antibodies with improved selectivity and potency. Based in New York City and Waltham, Mass., Dianthus is comprised of an experienced team of biotech and pharma executives who are leading the development of next-generation antibody complement therapeutics, aiming to deliver transformative medicines for people living with severe autoimmune and inflammatory diseases.

To learn more, please visit www.dianthustx.com and follow us on LinkedIn. 

Contact
Jennifer Davis Ruff
Dianthus Therapeutics
jdavisruff@dianthustx.com

FAQ

When is Dianthus Therapeutics (DNTH) presenting at the Jefferies Healthcare Conference 2025?

Dianthus Therapeutics will present at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025 at 9:55 a.m. EDT in New York City.

Who will represent Dianthus Therapeutics (DNTH) at the Jefferies Conference 2025?

Marino Garcia, Chief Executive Officer of Dianthus Therapeutics, will represent the company at the conference through a fireside chat and one-on-one investor meetings.

How can investors access Dianthus Therapeutics' (DNTH) presentation at the Jefferies Conference?

Investors can access a live webcast of the presentation through the 'News and Events' section in the Investors area of the Dianthus Therapeutics website.

What is Dianthus Therapeutics' (DNTH) main business focus?

Dianthus Therapeutics is a clinical-stage biotechnology company focused on developing next-generation antibody complement therapeutics for treating severe autoimmune diseases.